Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ABUS stock: Arbutus Biopharma Corp

Current Rating
Strong Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$3.20
Market Cap
148.1M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
0.34
P/S
9.89
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-59.7K
FCF
-1.1
Op. Margin
-
Net Margin
-
ROE
-35.30%
ROI
-15.90%
ROA
-27.70%
EPS Growth
-113.60%
Current Ratio
17.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Spine Injury Solutions Inc (SPIN) $0.40 - - 7M Strong Buy
Cleveland BioLabs, Inc. (CBLI) $1.54 - - 17.9M Strong Buy
ProPhase Labs Inc (PRPH) $1.99 - - 34.7M Strong Buy
STRATA Skin Sciences Inc (SSKN) $0.61 - - 6.1M Strong Buy
Navidea Biopharmaceuticals Inc (NAVB) $0.58 - - 76M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More